July 20, 2026 a 04:38 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. remains a prominent innovator in the medical technology sector, offering advanced tools that support minimally invasive treatment procedures. With sustained demand for its da Vinci Surgical System and expanding applications, analyst sentiment surrounding ISRG continues to reflect cautious optimism. Recent trends indicate a shift toward more moderate ratings as analysts weigh industry dynamics and competitive pressures.
Historical Stock Grades
As of July 2026, analyst ratings show a balanced sentiment with a notable number of positive recommendations. While there's robust support in 'Buy' categories, a modest presence of 'Sell' recommendations suggests a cautious approach among some analysts.
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 6 | |
| Buy | 17 | |
| Hold | 10 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Examining the sentiment changes over the past months, the data indicates fluctuations in analyst recommendations. Notable patterns include:
- A transition from 'Strong Buy' to 'Buy' in recent months, with 'Strong Buy' decreasing from previous levels.
- 'Hold' recommendations remaining relatively stable, reflecting some market uncertainty.
- 'Sell' and 'Strong Sell' ratings remain low, reflecting sustained belief in the company's prospects despite slight downward revisions in sentiment.
Percentage Trends
Inspecting percentage trends, there's a visible shift in sentiment with a greater emphasis on 'Buy' ratings compared to 'Strong Buy'. Specific observations include:
- The 'Buy' category currently accounts for approximately 49% of the ratings, while 'Strong Buy' has lessened to 17%.
- 'Hold' ratings, at 29%, highlight a conservative stance adopted by several analysts amidst broader industry factors.
- There has been a subtle transition towards less aggressive positive ratings, possibly indicating more reserved market expectations.
Latest Analyst Recommendations
Recent analyst feedback for ISRG highlights a consistent perspective, with no major shifts in ratings. The latest evaluations are as follows:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-07-17 | Outperform | Outperform | Baird |
| 2026-07-17 | Outperform | Outperform | Raymond James |
| 2026-07-17 | Overweight | Overweight | Piper Sandler |
| 2026-07-17 | Outperform | Outperform | RBC Capital |
| 2026-07-17 | Overweight | Overweight | JP Morgan |
Analyst Recommendations with Change of Opinion
Over recent months, ISRG has experienced targeted adjustments in ratings, reflecting dynamic market considerations. Key changes include:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-11 | Buy | Neutral | Citigroup |
| 2026-01-27 | Buy | Hold | Freedom Capital Markets |
| 2026-01-26 | Buy | Hold | Freedom Broker |
| 2025-12-11 | Neutral | Buy | Citigroup |
| 2025-06-09 | Sell | Hold | Deutsche Bank |
Interpretation
The overall market sentiment related to ISRG indicates varied perspectives among analysts, with a balanced view becoming more prevalent. Analysts are displaying pragmatic caution, reflective of broader market conditions and competitive pressures. The optimism in the 'Buy' recommendations signifies confidence in the company’s ongoing innovative potential, yet the growing inclination towards 'Hold' suggests careful monitoring ahead. This mixed sentiment demonstrates both stability in expectations and awareness of potential headwinds.
Conclusion
Intuitive Surgical, Inc. retains its standing as a formidable entity in medical technology, showcasing distinguished strengths through its cutting-edge product line. Despite consistent 'Buy' endorsements, subdued enthusiasm in 'Strong Buy' hints at measured optimism. The observed trends reveal a marketplace vigilant of evolving competitive challenges and sector shifts. The trajectory remains demand-responsive; thus, continuing product innovation and adaptive strategy are integral for sustaining analyst favor.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years